AI Verdict
HSCT has stronger fundamentals based on our AI analysis.
HSCT vs HRTX Fundamental Comparison
| Metric | HSCT | HRTX |
|---|---|---|
| Revenue | $0.0 | $154.9M |
| Net Income | $-33,021.0 | $-20.2M |
| Net Margin | N/A | -13.0% |
| ROE | N/A | -140.9% |
| ROA | -42.9% | -7.9% |
| Current Ratio | 0.28x | 2.48x |
| Debt/Equity | N/A | 0.00x |
| EPS | $0.00 | $-0.12 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
HSCT vs HRTX: Frequently Asked Questions
Is HSCT or HRTX a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), HSCT has stronger fundamentals. HSCT is rated STRONG SELL (98% confidence) while HRTX is rated STRONG SELL (87% confidence). This is not investment advice.
How does HSCT compare to HRTX fundamentally?
HOOPS SCOUTING USA has ROE of N/A vs HERON THERAPEUTICS, INC. /DE/'s -140.9%. Net margins are N/A vs -13.0% respectively.
Which stock pays higher dividends, HSCT or HRTX?
HSCT has a dividend yield of N/A or no dividend while HRTX has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in HSCT or HRTX for long term?
For long-term investing, consider that HSCT has STRONG SELL rating with 98% confidence, while HRTX has STRONG SELL rating with 87% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about HSCT vs HRTX?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For HSCT vs HRTX, the AI consensus favors HSCT based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.